Review



nsclc tumor  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    OriGene nsclc tumor
    Nsclc Tumor, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pmc03488578-174-14-38
    Average 90 stars, based on 4 article reviews
    nsclc tumor - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: The Hedgehog processing pathway is required for NSCLC growth and survival
    Article Snippet: .. Clinical expression and survival studies Clinical expression of SKN and DISP-1 was assessed in three different ways: A commercially available tumor cDNA array consisting of 24 matched pairs of human lung tumor and normal tissues was purchased and used per manufacturer’s instructions (TissueScan Lung Cancer cDNA Array IV, Origene Technologies), 6 pairs of locally obtained matched pairs of human lung tumor and normal tissue were analyzed by qRT-PCR, and a set of 58 tumor/normal pairs from NSCLC patients was analyzed using a custom Agilent Whole Genome Oligonucleotide micro-array as previously described 43 . ..

    Article Title: The Hedgehog processing pathway is required for NSCLC growth and survival
    Article Snippet: .. Clinical expression of SKN and DISP-1 was assessed in three different ways: A commercially available tumor cDNA array consisting of 24 matched pairs of human lung tumor and normal tissues was purchased and used per manufacturer’s instructions (TissueScan Lung Cancer cDNA Array IV, Origene Technologies), 6 pairs of locally obtained matched pairs of human lung tumor and normal tissue were analyzed by qRT-PCR, and a set of 58 tumor/normal pairs from NSCLC patients was analyzed using a custom Agilent Whole Genome Oligonucleotide micro-array as previously described 43 . ..

    Microarray:

    Article Title: The Hedgehog processing pathway is required for NSCLC growth and survival
    Article Snippet: .. Clinical expression and survival studies Clinical expression of SKN and DISP-1 was assessed in three different ways: A commercially available tumor cDNA array consisting of 24 matched pairs of human lung tumor and normal tissues was purchased and used per manufacturer’s instructions (TissueScan Lung Cancer cDNA Array IV, Origene Technologies), 6 pairs of locally obtained matched pairs of human lung tumor and normal tissue were analyzed by qRT-PCR, and a set of 58 tumor/normal pairs from NSCLC patients was analyzed using a custom Agilent Whole Genome Oligonucleotide micro-array as previously described 43 . ..

    Article Title: The Hedgehog processing pathway is required for NSCLC growth and survival
    Article Snippet: .. Clinical expression of SKN and DISP-1 was assessed in three different ways: A commercially available tumor cDNA array consisting of 24 matched pairs of human lung tumor and normal tissues was purchased and used per manufacturer’s instructions (TissueScan Lung Cancer cDNA Array IV, Origene Technologies), 6 pairs of locally obtained matched pairs of human lung tumor and normal tissue were analyzed by qRT-PCR, and a set of 58 tumor/normal pairs from NSCLC patients was analyzed using a custom Agilent Whole Genome Oligonucleotide micro-array as previously described 43 . ..



    Similar Products

    90
    OriGene nsclc tumor
    Nsclc Tumor, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pmc03488578-174-14-38
    Average 90 stars, based on 1 article reviews
    nsclc tumor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene mark4 mrna
    Figure 4. <t>MARK4</t> overexpression rescues the inhibitory effects of miR-515-5p on cell migration.
    Mark4 Mrna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pm26882547-284-10-20
    Average 90 stars, based on 1 article reviews
    mark4 mrna - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene lung cancer panel iv array
    Figure 4. <t>MARK4</t> overexpression rescues the inhibitory effects of miR-515-5p on cell migration.
    Lung Cancer Panel Iv Array, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pmc05239460__oncotarget___07___51082___s001-8-25-29
    Average 90 stars, based on 1 article reviews
    lung cancer panel iv array - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene com qpcr tissue qpcr arrays aspx
    Figure 4. <t>MARK4</t> overexpression rescues the inhibitory effects of miR-515-5p on cell migration.
    Com Qpcr Tissue Qpcr Arrays Aspx, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pm24865347-62-31-30
    Average 90 stars, based on 1 article reviews
    com qpcr tissue qpcr arrays aspx - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene tissuescan lung cancer tissue qpcr panels
    Figure 4. <t>MARK4</t> overexpression rescues the inhibitory effects of miR-515-5p on cell migration.
    Tissuescan Lung Cancer Tissue Qpcr Panels, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pm25114038-172-30-36
    Average 90 stars, based on 1 article reviews
    tissuescan lung cancer tissue qpcr panels - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene tissuescan, lung cancer cdna array iv
    Figure 4. <t>MARK4</t> overexpression rescues the inhibitory effects of miR-515-5p on cell migration.
    Tissuescan, Lung Cancer Cdna Array Iv, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/origene___hlrt104
    Average 90 stars, based on 1 article reviews
    tissuescan, lung cancer cdna array iv - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    OriGene tissuescan lung cancer cdna array iv
    a, SKN and b, DISP-1 are differentially expressed in NSCLCs as compared to the corresponding matched normal lung tissue. Expression levels from 58 matched NSCLC/normal lung tissue pairs were assessed by oligonucleotide micro-array analyses. Gene expression in NSCLC was normalized to matched normal tissue and plotted as the Log10 change (tumor/normal). c, SKN is overexpressed in commercially available clinical lung cancer specimens, confirming the pattern of expression detected by micro-array analysis. These were purchased from Origene <t>(Tissuescan</t> Lung Cancer <t>cDNA</t> Array IV) and consist of 24 matched lung cancer/normal lung cDNA pairs pre-normalized to β-ACTIN. SKN expression was determined by qRT-PCR, and lung tumor expression was normalized to matched normal control. d, DISP-1 is differentially expressed in clinical lung cancer specimens. The same Tissuescan cDNA array was used to assess DISP-1 levels by qRT-PCR. Arrows represent pairs where DISP-1 expression was below the threshold of detection in either normal lung tissue (up arrow) or lung tumor (down arrow). e, Higher DISP-1 expression is associated with reduced recurrence free survival. A publically available dataset (GSE8894) consisting of micro-array profiles of 138 NSCLC cases and an associated clinical survival database (recurrence-free survival) was mined to find correlations between DISP-1 expression and recurrence free survival. Lung cancers were separated into tertiles based on DISP-1 expression, and the top third compared to the bottom third. f, Higher DISP-1 expression is associated with reduced survival in a second publically available dataset (GSE10245) consisting of micro-array profiles of 58 NSCLC cases and an associated clinical outcome database (overall and progression-free survival). This dataset was analyzed in the same manner as for GSE10245. P-values reported are from a one-tailed Log-rank (Mantel-Cox) test.
    Tissuescan Lung Cancer Cdna Array Iv, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissuescan+lung+cancer+cdna+array+iv/TissueScan%2C+Lung+Cancer+cDNA+Array+IV/pmc03821972-320-5-4
    Average 90 stars, based on 1 article reviews
    tissuescan lung cancer cdna array iv - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4. MARK4 overexpression rescues the inhibitory effects of miR-515-5p on cell migration.

    Journal: EMBO reports

    Article Title: miR-515-5p controls cancer cell migration through MARK4 regulation.

    doi: 10.15252/embr.201540970

    Figure Lengend Snippet: Figure 4. MARK4 overexpression rescues the inhibitory effects of miR-515-5p on cell migration.

    Article Snippet: Lung cancer versus normal lung cDNA arrays The levels for MARK4 mRNA were determined in the HLRT104 TissueScan cDNA array (Origene) containing 24 lung cancer and matching normal lung samples and were analysed by using the Fast SYBR Green PCR Master Mix and 7900HT Real-time PCR System (Applied Biosystems).

    Techniques: Over Expression, Migration

    Figure 7. miR-515-5p overexpression or siRNA-mediated MARK4 silencing prevents A549 cell metastasis to the lung. A549-Luc cells transfected either with miR-515-5p precursor (miR), siRNAs to MARK4 (siMARK4) or the corresponding control sequences (C and NT, respectively) were injected in SCID mice through the tail vein. Four weeks later, the mice were sacrificed and their lungs extracted and fixed prior to staining for luciferase expression.

    Journal: EMBO reports

    Article Title: miR-515-5p controls cancer cell migration through MARK4 regulation.

    doi: 10.15252/embr.201540970

    Figure Lengend Snippet: Figure 7. miR-515-5p overexpression or siRNA-mediated MARK4 silencing prevents A549 cell metastasis to the lung. A549-Luc cells transfected either with miR-515-5p precursor (miR), siRNAs to MARK4 (siMARK4) or the corresponding control sequences (C and NT, respectively) were injected in SCID mice through the tail vein. Four weeks later, the mice were sacrificed and their lungs extracted and fixed prior to staining for luciferase expression.

    Article Snippet: Lung cancer versus normal lung cDNA arrays The levels for MARK4 mRNA were determined in the HLRT104 TissueScan cDNA array (Origene) containing 24 lung cancer and matching normal lung samples and were analysed by using the Fast SYBR Green PCR Master Mix and 7900HT Real-time PCR System (Applied Biosystems).

    Techniques: Over Expression, Transfection, Control, Injection, Staining, Luciferase, Expressing

    a, SKN and b, DISP-1 are differentially expressed in NSCLCs as compared to the corresponding matched normal lung tissue. Expression levels from 58 matched NSCLC/normal lung tissue pairs were assessed by oligonucleotide micro-array analyses. Gene expression in NSCLC was normalized to matched normal tissue and plotted as the Log10 change (tumor/normal). c, SKN is overexpressed in commercially available clinical lung cancer specimens, confirming the pattern of expression detected by micro-array analysis. These were purchased from Origene (Tissuescan Lung Cancer cDNA Array IV) and consist of 24 matched lung cancer/normal lung cDNA pairs pre-normalized to β-ACTIN. SKN expression was determined by qRT-PCR, and lung tumor expression was normalized to matched normal control. d, DISP-1 is differentially expressed in clinical lung cancer specimens. The same Tissuescan cDNA array was used to assess DISP-1 levels by qRT-PCR. Arrows represent pairs where DISP-1 expression was below the threshold of detection in either normal lung tissue (up arrow) or lung tumor (down arrow). e, Higher DISP-1 expression is associated with reduced recurrence free survival. A publically available dataset (GSE8894) consisting of micro-array profiles of 138 NSCLC cases and an associated clinical survival database (recurrence-free survival) was mined to find correlations between DISP-1 expression and recurrence free survival. Lung cancers were separated into tertiles based on DISP-1 expression, and the top third compared to the bottom third. f, Higher DISP-1 expression is associated with reduced survival in a second publically available dataset (GSE10245) consisting of micro-array profiles of 58 NSCLC cases and an associated clinical outcome database (overall and progression-free survival). This dataset was analyzed in the same manner as for GSE10245. P-values reported are from a one-tailed Log-rank (Mantel-Cox) test.

    Journal: Oncogene

    Article Title: The Hedgehog processing pathway is required for NSCLC growth and survival

    doi: 10.1038/onc.2012.243

    Figure Lengend Snippet: a, SKN and b, DISP-1 are differentially expressed in NSCLCs as compared to the corresponding matched normal lung tissue. Expression levels from 58 matched NSCLC/normal lung tissue pairs were assessed by oligonucleotide micro-array analyses. Gene expression in NSCLC was normalized to matched normal tissue and plotted as the Log10 change (tumor/normal). c, SKN is overexpressed in commercially available clinical lung cancer specimens, confirming the pattern of expression detected by micro-array analysis. These were purchased from Origene (Tissuescan Lung Cancer cDNA Array IV) and consist of 24 matched lung cancer/normal lung cDNA pairs pre-normalized to β-ACTIN. SKN expression was determined by qRT-PCR, and lung tumor expression was normalized to matched normal control. d, DISP-1 is differentially expressed in clinical lung cancer specimens. The same Tissuescan cDNA array was used to assess DISP-1 levels by qRT-PCR. Arrows represent pairs where DISP-1 expression was below the threshold of detection in either normal lung tissue (up arrow) or lung tumor (down arrow). e, Higher DISP-1 expression is associated with reduced recurrence free survival. A publically available dataset (GSE8894) consisting of micro-array profiles of 138 NSCLC cases and an associated clinical survival database (recurrence-free survival) was mined to find correlations between DISP-1 expression and recurrence free survival. Lung cancers were separated into tertiles based on DISP-1 expression, and the top third compared to the bottom third. f, Higher DISP-1 expression is associated with reduced survival in a second publically available dataset (GSE10245) consisting of micro-array profiles of 58 NSCLC cases and an associated clinical outcome database (overall and progression-free survival). This dataset was analyzed in the same manner as for GSE10245. P-values reported are from a one-tailed Log-rank (Mantel-Cox) test.

    Article Snippet: These were purchased from Origene (Tissuescan Lung Cancer cDNA Array IV) and consist of 24 matched lung cancer/normal lung cDNA pairs pre-normalized to β- ACTIN .

    Techniques: Expressing, Microarray, Quantitative RT-PCR, One-tailed Test